Cardiology

  • Interpreting SPRINT: How low should you go?
    George Thomas, MD, FACP, FASN, Joseph V. Nally, MD and Marc A. Pohl, MD
    Cleveland Clinic Journal of Medicine March 2016, 83 (3) 187-195; DOI: https://doi.org/10.3949/ccjm.83a.15175

    In treating hypertension, lower systolic pressure is better than higher—but with caveats.

  • Blood pressure management in the wake of SPRINT
    Edward J. Filippone, MD, FACP and Andrew J. Foy, MD
    Cleveland Clinic Journal of Medicine March 2016, 83 (3) 196-198; DOI: https://doi.org/10.3949/ccjm.83a.16015

    SPRINT should be interpreted in the context of prior trials and of its inclusion and exclusion criteria.

  • The intersection of obstructive lung disease and sleep apnea
    The intersection of obstructive lung disease and sleep apnea
    Sumita B. Khatri, MD, MS and Octavian C. Ioachimescu, MD, PhD
    Cleveland Clinic Journal of Medicine February 2016, 83 (2) 127-140; DOI: https://doi.org/10.3949/ccjm.83a.14104

    Many patients who have chronic obstructive pulmonary disease or asthma also have obstructive sleep apnea, and vice versa.

  • Prescribing exercise to help your patients lose weight
    John P. Higgins, MD, MBA, MPhil and Christopher L. Higgins, MCEP, BSHPE
    Cleveland Clinic Journal of Medicine February 2016, 83 (2) 141-150; DOI: https://doi.org/10.3949/ccjm.83a.14139

    It’s not enough to tell patients to exercise. The exercise you prescribe needs to be “SMART.”

  • Obesity and exercise
    Cleveland Clinic Journal of Medicine February 2016, 83 (2) 151; DOI: https://doi.org/10.3949/ccjm.83pe.02001
  • Hope may not be the best component of an exercise regimen
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine February 2016, 83 (2) 89; DOI: https://doi.org/10.3949/ccjm.83b.02016

    Exercising to lose weight more often results in frustration than a trip to the store to buy smaller-sized clothes.

  • Can patients opt to turn off implantable cardioverter-defibrillators near the end of life?
    M. Motaz Baibars, MD, M. Chadi Alraies, MD, FACP, Amjad Kabach, MD and Marc Pritzker, MD, FACC
    Cleveland Clinic Journal of Medicine February 2016, 83 (2) 97-98; DOI: https://doi.org/10.3949/ccjm.83a.15007

    Yes, it is reasonable to consider deactivation near the end of life if the patient or family wishes.

  • The ethics of ICDs: History and future directions
    Martin L. Smith, STD and Eric Kodish, MD
    Cleveland Clinic Journal of Medicine February 2016, 83 (2) 99-100; DOI: https://doi.org/10.3949/ccjm.83a.15122

    There is no ethical requirement that treatment, once started, must continue against the patient’s wishes.

  • Obstructive sleep apnea: Who should be tested, and how?
    Mahesh B. Manne, MD, MPH and Gregory Rutecki, MD
    Cleveland Clinic Journal of Medicine January 2016, 83 (1) 25-27; DOI: https://doi.org/10.3949/ccjm.83a.14074

    Only 10% of people with obstructive sleep apnea are diagnosed—a dismal statistic, considering the consequences.

  • Approach to asymptomatic creatine kinase elevation
    Siamak Moghadam-Kia, MD, Chester V. Oddis, MD and Rohit Aggarwal, MD, MS
    Cleveland Clinic Journal of Medicine January 2016, 83 (1) 37-42; DOI: https://doi.org/10.3949/ccjm.83a.14120

    Standard cutoffs may be too low. First, repeat the test after 7 days without exercise.

Pages